Skip to main content
All lobbying filings

FIERCE GOVERNMENT RELATIONS

Lobbying for ASSOCIATION OF ACCESSIBLE MEDICINES (FORMERLY KNOWN AS GPHA) · Trade Organization for Generic Drug Manufacturers and Distributers

 Filing 2nd Quarter - Report
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $60,000.00 income · posted Jul 21, 2025

Official filing document

 Bills named in this filing 5
  • S 1041
    Affordable Prescriptions for Patients Act
  • S 43
    Skinny Labels, Big Savings Act
  • S 1302
    Increasing Transparency in Generic Drug Applications Act
  • S 1954
    Biosimilar Red Tape Elimination Act
  • S 1414
    Expedited Access to Biosimilars Act
 Lobbying activity 1
Pharmacy

Supply Chain, Drug Shortages, Tariffs, Patent Thickets, S.1041 - Affordable Prescriptions for Patients Act, S.43 - Skinny Labels - Big Savings Act, S.1302 - A Bill to Provide for Increased Transparency in Generic Drug Applications, S.1954- Biosimilar Red Tape Reduction Act, S.1414 - Expected Access to Biosimilars Act, Access to Biosimilars, Generic Manufacturing Marketplace Issues

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem